Notice: This company has been marked as potentially delisted and may not be actively trading. Lumos Pharma (LUMO) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lumos Pharma (NASDAQ:LUMO)CurrentInstitutional OwnershipPercentage33.99%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.77MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$699.16K Get LUMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LUMO Institutional Buying and Selling by Quarter Remove Ads Lumos Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/22/2024 Private Advisor Group LLC744,513$2.88M0.0%+2,380.6%9.173% 5/16/2024 Blackstone Inc.78,624$222K0.0%-75.9%0.968% 2/15/2024 Blackstone Inc.326,552$1.04M0.0%-30.2%4.128% 2/6/2024 Private Advisor Group LLC16,013$51K0.0%-20.0%0.202% 11/7/2023 Greenwich Wealth Management LLC76,341$252K0.0%+55.8%0.961% 11/3/2023 Private Advisor Group LLC20,013$66K0.0%+42.8%0.252% 10/27/2023 Marquette Asset Management LLC25,760$85K0.0%-17.1%0.324% 10/27/2023 Acuitas Investments LLC125,242$413K0.2%-18.6%1.577% 8/10/2023 Private Advisor Group LLC14,013$46K0.0%-30.0%0.172% 7/31/2023 Greenwich Wealth Management LLC49,002$162K0.0%+63.2%0.600% Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 5/1/2023 Marquette Asset Management LLC31,088$103K0.0%+47.9%0.379% 4/24/2023 Greenwich Wealth Management LLC30,028$99K0.0%N/A0.366% 2/10/2023 K2 Principal Fund L.P.15,836$57K0.0%-71.7%0.189% 1/18/2023 Private Advisor Group LLC20,013$72K0.0%+17.6%0.238% 1/12/2023 Marquette Asset Management LLC21,020$76K0.0%+57.9%0.250% 10/14/2022 Private Advisor Group LLC17,013$151K0.0%-37.0%0.203% 8/15/2022 Opaleye Management Inc.21,520$166K0.1%N/A0.257% 7/26/2022 Key Financial Inc10,916$84K0.0%N/A0.130% 7/22/2022Urban Wealth Management LLC3,490$27K0.1%N/A0.042% 2/15/2022 Lion Point Capital LP51,205$354K0.1%-87.4%0.613% 2/4/2022 Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124% 2/2/2022 PVG Asset Management Corp10,175$71K0.3%N/A0.122% 1/14/2022Investors Financial Group LLC30,600$212K0.1%-11.6%0.366% 11/15/2021 Minerva Advisors LLC34,015$321K0.2%N/A0.407% 11/12/2021 Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.33,427$318K0.0%+4.7%0.400% 10/21/2021Investors Financial Group LLC34,600$329K0.2%+16.9%0.414% 10/12/2021 Marquette Asset Management LLC13,234$126K0.0%+48.4%0.158% 8/17/2021 Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910% 8/16/2021 Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571% 8/16/2021 State Street Corp11,237$112K0.0%N/A0.134% 8/13/2021 Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659% 8/12/2021 Dimensional Fund Advisors LP39,405$392K0.0%-5.0%0.472% 8/12/2021 Connor Clark & Lunn Investment Management Ltd.31,938$317K0.0%-4.1%0.382% 7/19/2021 Marquette Asset Management LLC8,919$89K0.0%N/A0.107% 5/18/2021 Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516% 5/17/2021 Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471% 5/14/2021 Dimensional Fund Advisors LP41,459$485K0.0%-4.8%0.497% 5/13/2021 Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983% 5/12/2021 Northern Trust Corp2,960$35K0.0%-75.5%0.035% Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before April 23rd5/11/2021 Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070% 5/7/2021BlackRock Inc.71,078$831K0.0%+2.9%0.853% 4/14/2021Investors Financial Group LLC29,200$342K0.2%+60.4%0.350% 2/22/2021 West Financial Advisors LLC784$28K0.0%N/A0.009% 2/18/2021 Verition Fund Management LLC9,835$351K0.0%N/A0.119% 2/11/2021 Northern Trust Corp12,081$432K0.0%+292.0%0.146% 2/9/2021 Bank of New York Mellon Corp17,493$625K0.0%N/A0.211% (Data available from 1/1/2016 forward)Remove Ads LUMO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUMO shares? During the previous two years, the following institutional investors and hedge funds held shares of Lumos Pharma shares: Private Advisor Group LLC ($2.88M), Acuitas Investments LLC ($413K), Greenwich Wealth Management LLC ($252K), and Blackstone Inc. ($222K), Marquette Asset Management LLC ($85K).Learn more on LUMO's institutional investors. What percentage of Lumos Pharma stock is owned by institutional investors? 33.99% of Lumos Pharma stock is owned by institutional investors. Learn more on LUMO's institutional investor holdings. Which institutional investors have been buying Lumos Pharma stock? The following institutional investors have purchased Lumos Pharma stock in the last 24 months: Private Advisor Group LLC ($720.50K), Greenwich Wealth Management LLC ($76.34K), and Marquette Asset Management LLC ($10.07K). How much institutional buying is happening at Lumos Pharma? Institutional investors have bought a total of 806,909 shares in the last 24 months. This purchase volume represents approximately $3.07M in transactions. Which Lumos Pharma major shareholders have been selling company stock? The following institutional investors have sold Lumos Pharma stock in the last 24 months: Blackstone Inc. ($389.52K), Acuitas Investments LLC ($28.63K), Private Advisor Group LLC ($10K), and Marquette Asset Management LLC ($5.33K). How much institutional selling is happening at Lumos Pharma? Institutional investors have sold a total of 433,474 shares in the last 24 months. This volume of shares sold represents approximately $1.29M in transactions. Related Companies scPharmaceuticals Institutional Ownership Inventiva Institutional Ownership C4 Therapeutics Institutional Ownership Compugen Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership Actuate Therapeutics Institutional Ownership Artiva Biotherapeutics Institutional Ownership Instil Bio Institutional Ownership ProQR Therapeutics Institutional Ownership MacroGenics Institutional Ownership This page (NASDAQ:LUMO) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lumos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
